The Global Alliance for Chronic Diseases (GACD) supports international and interdisciplinary collaborations in research, focusing on chronic non-communicable diseases.
The GACD places particular emphasis on research into cardiovascular diseases (mainly heart disease and stroke), type 2 diabetes, chronic respiratory conditions, mental health and several cancers. The work of the GACD focuses on the needs of low and middle income countries (LMICs) and on low income populations in more developed countries.
Current members of the GACD include:
- Chinese Academy of Medical Sciences (CAMS)
- Canadian Institutes of Health Research (CIHR)
- Research and Innovation DG, European Commission (EC)
- Indian Council of Medical Research (ICMR)
- Medical Research Council, UK (MRC)
- Institutes of Health, USA (NIH)
- National Health and Medical Research Council (NHMRC)
- Medical Research Council, South Africa (MRC)
- Mexico’s National Institute of Medical Sciences and Nutrition.
In 2011, the National Health and Medical Research Council (NHMRC) participated in the first GACD joint initiative: a call for research on hypertension in low and middle income countries. NHMRC committed $5 million to the implementation of programs designed to control and prevent hypertension and reduce the associated disease burden in target communities.
Grants were awarded for teams of researchers to examine the efficacy of preventative and control-based approaches while building on previous research. Funding was provided for up to three years.
Global Alliance for Chronic Disease (GACD) Request for Applications: Prevention and treatment of Type 2 Diabetes
NHMRC is participating in a GACD Request for Applications (RFA) on the prevention and treatment of Type 2 Diabetes in Low and Middle Income Countries (LMIC). This RFA closed on 11 July 2014.
As part of this call, NHMRC invited proposals addressing the prevention and treatment of type 2 diabetes in Aboriginal and Torres Strait Islander populations.
The aim of this call was to fund projects that will generate new knowledge on interventions and their implementation for the prevention and treatment of type 2 diabetes in either, low and middle income countries (LMIC) as defined by The World Bank, or in Aboriginal and Torres Strait Islander populations.
Full details of the aim, scope and assessment criteria of this call can be found on the GACD website.
The RFA was undertaken in a two stage process:
- Letter of Intent (LOI), reviewed by expert peers selected by the NHMRC. Applications favourably assessed at this stage were invited by the NHMRC to submit full applications.
- Full applications were reviewed by a joint panel of international peers selected by participating GACD agencies.
- Letters of Intent OPENED - October 31 2013
- Letters of Intent CLOSED - January 30 2014
- *Full Applications OPENED - 12 May 2014
- Full Applications CLOSED - 11 July 2014
Full applications stage
The full application stage of the NHMRC/GACD Request for Applications (RFA) on Type 2 Diabetes in Low and Middle Income Countries opened on 12 May 2014 and closed on 11 July 2014.
Documentation relating to the RFA is provided below for archival purposes:
- NHMRC/GACD Request for Applications on Type 2 diabetes in Low and Middle Income Countries Scheme Specific Information for funding in 2014
- NHMRC/GACD Request for Applications on Type 2 diabetes in Low and Middle Income Countries Advice and Instructions to Applicants (PDF, 332KB)
- Media release: Members of GACD to fund landmark research initiative to reduce impact of diabetes
- Media release: Australian Smart Phone Research to Combat Chronic Disease in Lower and Middle Income Countries
NHMRC – Global Alliance for Chronic Disease
Research Programs Branch
GPO Box 1421
CANBERRA ACT 2601
Page last updated on 17 November 2014